← All stocks

Onconetix, Inc.

ONCO Balanced
CIK 0001782107 #5552 in the set updated 17 Sep 2026
Bought (12 mo)
$152.87K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$144.47K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$144.47K
3 of 3 sales
Net
+$8.41K
+$8.41K against sales at will

By person

10 insiders · 6 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
HRT FINANCIAL LP entity
10% owner
$152.87K (3)
$144.47K (3)
+$8.41K
33,649
$23.22K
+11.6%
Schiess Ralph
Interim CEO, CSO
673,365
$464.62K
+9,886%
Bruhlmann Christian
Chief Strategy Officer
611,372
$421.85K
+10,262%
Altos Venture AG
10% owner
273,230
$188.53K
+761.5%
SAPIRSTEIN JAMES
Director
3,477
$2.40K
+2,087%
SINGH AJIT
Director
3,396
$2.34K
+4,254%
Tarsh Simon
Director
658
$454.02
Ramdeen Timothy R.
Director
658
$454.02
Meier Thomas
Director
657
$453.33
Oakley Andrew John
Director
638
$440.22

No percentages here. This company's share count has moved by a factor of 28.4 over the window, from 1,560,668 to 44,358,422 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
HRT FINANCIAL LP
21 Apr 2026
10% owner
Sell
49,710
$0.69
$34.30K
HRT FINANCIAL LP
20 Apr 2026
10% owner
Sell
94,462
$0.75
$70.85K
HRT FINANCIAL LP
16 Apr 2026
10% owner
Sell
53,867
$0.73
$39.32K

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 0
History held since 24 Feb 2022